NCT01588184 2020-11-05An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored StudyHoffmann-La RochePhase 4 Completed95 enrolled 15 charts